Publicación de Oncoliq

Exciting news: The consortium led by ParaMedir B.V. is awarded with more than €1.8 Million in European Funding by Just Transition Fund (JTF) to advance Healthcare through innovative biomonitoring solutions! 🚀 This funding supports the consortium which includes Pieter Oomen Beheer, Health Hub Roden, GitGud Software Development, University Medical Center Groningen (UMCG), Zorggroep Tangenborgh, and Hanze University Groningen in advancing healthcare through innovative biomonitoring solutions by tackling the challenges of diagnosing and monitoring acute and chronic illnesses. The goal is to enhance biomonitoring for patients with acute and chronic illnesses, such as diabetes, adhering to the "better in, better out" principle. Want to know more? Check out the full article 👉 https://lnkd.in/e8kPaF2C

We are finally able to announce that Sense4Care is in collaboration with the Consorci Sanitari Alt Penedès-Garraf which has secured funding for the MoMoPa-AM project, led by Dr. Alejandro Rodríguez-Molinero and Dr. Carlos Pérez López. This project aims to revolutionize mobility monitoring for Parkinson’s patients, a significant milestone in our ongoing MoMoPa research journey since 2009. With a total funding nearing 500,000 euros, MoMoPa-AM combines scientific investigation with entrepreneurial focus, reflecting our commitment to advancing healthcare technology, bringing together neurology experts from across the country. MoMoPa-AM will leverage cutting-edge sensor technologies to enhance symptom identification and enable personalized treatment interventions. By collecting objective mobility data from 100 patients over 6 hours each, our algorithmic approach will autonomously detect Parkinson’s motor symptoms, even during immobility. Another goal is to improve dyskinesia’s algorithm to provide a degree of severity. The outcomes of MoMoPa-AM will drive the development of an innovative monitoring solution, filling a critical gap in current Parkinson’s care. https://lnkd.in/dXygeSyT Stay tuned for updates on this transformative project! #ParkinsonsResearch #HealthTech #Innovation #Machinelearning #Medicaldevices #Realscience #Parkinsonsdisease #Parkinson #medtech #STATON #digitalhealth Daniel Rodríguez-Martín Chiara Capra Albert Pagès Raventós Joan Cabestany andreu catala mallofre

Elevating patient voices is one of our ongoing priorities. The most powerful and informative way for potential clinical trial participants to learn what participation is like is to hear from someone who has been through it. #clinicaltrials #patientcentricity #patientvoice

Excited to share the groundbreaking news from ABC News about the Mayo Clinic's unprecedented $5 billion expansion in Rochester! This ambitious endeavor goes beyond physical growth, as it aims to revolutionize patient care and reshape healthcare infrastructure for the future. At the core of the expansion are adaptable buildings designed for evolving healthcare needs, ensuring Mayo Clinic stays at the forefront of medical innovation. The creation of patient-centric 'neighborhoods' will centralize services for specific conditions, such as cancer, providing comprehensive care in a convenient location. Furthermore, Mayo Clinic is leading the way in integrating digital and in-person care, leveraging artificial intelligence to enhance patient outcomes and accelerate the development of novel treatments. This expansion project reflects Mayo Clinic's unwavering commitment to healthcare innovation, going beyond constructing buildings to transforming the entire healthcare experience. The goal is to establish a new standard for healthcare facilities globally, setting the stage for increased innovation and world-class care worldwide. Construction is set to commence in 2024, with the first facilities expected to be operational by 2028 and the entire project completed by 2030. It's truly a new dawn in healthcare, and Mayo Clinic is paving the way for a future of superior patient care. #healthcareinnovation #MayoClinicExpansion #FutureofHealthcare https://ayr.app/l/Nqi2

🌟 Recap of a Stimulating Panel Discussion on Digital Healthcare! 🌟 Our panel delved into the fascinating realm of "EHRs to Multiomics: The Next Digital Healthcare Frontier" at the Nag Auditorium, offering profound insights into the future of healthcare. Here's a recap: 🎤 Hosted by: Prof. Saket Choudhary, Assistant Professor, Koita Centre for Digital Health - KCDH (IIT Bombay) the session expertly navigated the transformative potential of digital technologies in healthcare. 💡 Panelists: - Dr. Bharat Aggarwal, Principal Director-Radiology Services, Max Healthcare - Dr. seema gulia, Professor of Medical Oncology, Tata Memorial Hospital - Dr. Nikesh R. Shah, CEO, National Cancer Grid-Koita Centre for Digital Oncology (KCDO) Together, the panelists painted a compelling picture of the evolving landscape of digital healthcare, emphasizing the potential of data-driven approaches to enhance patient care and advance medical research. Let's continue to explore and innovate in digital healthcare, paving the way towards a healthier and more connected future for all! #DigitalHealthcare #EHRs #Multiomics #HealthTech #PanelDiscussion #HealthcareInnovation #SessionRecap #TransformativeHealthcare

A Letter from the ASCAT Program Chair: Insights, Innovations, and Collaborative Action Await To My Fellow ASCAT Conference Attendees, Over the last decade, we have witnessed unprecedented advances in research as well as the development of long-awaited new treatments for individuals affected by Sickle Cell Disease and Thalassaemia. This remarkable progress, as well as the impressive pipeline of potential new therapies, will be highlighted during ASCAT 2024. We will hear the lived experiences and perspectives of those directly affected by Haemoglobinopathies and the advocacy and legislative actions being taken to address remaining concerns. We will learn from experts across the globe about a variety of topics including pre-conception counseling, newborn screening, organ damage, access to care, and algorithms to choose the best course of treatment for each individual patient. As we developed this year’s program, we wanted to be certain to balance our celebration of the marked progress in treatment options with the reality that this progress has not been equally meaningful for all who are affected. Our conference theme embodies this sentiment: “Achieving Equitable Progress: A Call for Collaborative Action in a World of Growing Disparities.” As such, ASCAT 2024 will have didactic sessions, panel discussions, and ample networking time to understand and enhance global efforts to narrow the evolving disparities in diagnostic, care, and treatment access. We especially encourage young and promising researchers, doctors, and students to join us. Your fresh perspectives and innovative ideas are crucial to the continued advancement of our field. This is a unique opportunity to learn, share, and network with leading experts and peers dedicated to closing the Haemoglobinopathy equity gap. I look forward to welcoming you to ASCAT 2024! Biree Andemariam, M.D. #ASCAT2024 www.ascatconferences.com

A new peer-learning event is coming to The Rounds: Addressing the Challenges of Anaemia and Thrombocytopenia in Myelofibrosis! Gain perspectives from Dr. Vikas Gupta and Dr. Shireen Sirhan and expect them to: ✅ Provide an overview of myelofibrosis and the significant burden of disease among patients with myelofibrosis ✅ Discuss the current treatment options for myelofibrosis and their limitations in the management of anaemia and thrombocytopenia ✅ Review clinical trial data for emerging therapies and discuss the clinical decision-making for patients with myelofibrosis Learn more about our experts⁠⁠ and this must-attend event: https://loom.ly/_nj4ltc #Hematology #Oncology #Anaemia Come for the learning. Stay for the community. Be part of The Rounds.

We work to close the care gap. Excerpts from JUL 23 CMO Corner (https://lnkd.in/eN4ABu9v) Patient centricity has long been a buzzword in the clinical trial community, but the concept is slowly beginning to take hold. It’s a re-setting of goals beyond collecting data from “subjects,” to the intentional inclusion of the real-world needs of patients and their caregivers. The pandemic actually helped to move the needle when it forced creative solutions that ultimately reduced patient burdens connected to clinical studies. Remote monitoring, allowing patients to get lab work at locations closer to home and even shipping drugs to patients homes are now finding their way into standard trial practice. While these logistical improvements are beneficial, we still have a long way to go to making patients true partners in clinical research, and ASCO 2023 president Eric P. Winer, set a challenge to “,,, unequivocally recommit ourselves to patients . . . Better, more equitable and engaged cancer care hinges on forging deeper, more meaningful relationships between oncology clinicians and the people we care for.” When everyone from trial designers to those who review and analyze data recognizes the value of this approach, both the efficiency and effectiveness of trials will be improved. Costs will be reduced and lessons learned will be more quickly translated into clinical practice. CROs who innovate and evolve in guiding studies to serve the greater healthcare community and patients in all parts of the world will play a large part in this transformation. At George Clinical it has always been our mission to improve the quality of life and the access to the best treatments for all people regardless of their demographic or economic background, and this mission drives the way we approach clinical trials. #WorldCancerDay #CloseTheCareGap

NICE - National Institute for Health and Care Excellence and NHS England have announced a plan to accelerate the adoption of #innovative technologies in healthcare. This initiative ensures that clinically effective and cost-efficient technologies, like our oncology solution #Liberty, an at-home full blood count analyser, can reach patients quickly. Principle 3 is particularly important as it ensures automatic identification of funding to support routine commissioning and adoption of new technologies. This is a crucial and much-needed step for the NHS to meet capacity demands and achieve long-term cost savings. Read more about this development below 👇 https://lnkd.in/d2k7ihmj #HealthcareInnovation #CancerCare #MedicalTechnology

Raising awareness about early lymphedema detection among breast cancer patients is paramount to ensuring they seek and receive necessary care." Parmjot Bains , MBChB, M Phil, Managing Director & Interim CEO Learn more about how you can make a difference in lymphedema awareness during this Lymphedema Awareness Month. Read the full article featuring Dr. Bains here: https://ow.ly/ECTo50QXU0c #LymphedemaAwareness #EarlyDetection